title: [Therapy of Helicobacter pylori infection].
abstract: H. pylori eradication remains standard treatment for peptic ulcer disease. Until now, other indications like non-ulcer dyspepsia, reflux esophagitis, or concomitant medication with non-steroidal antirheumatics are not approved according to actual guidelines and these patients should be managed on an individual basis only. One week triple therapy consisting of a proton-pump inhibitor (PPI), a macrolide antibiotic (clarithromycin), and a imidazole antibiotic (metronidazole) or amoxicillin, given bid. Quadruple therapy including PPI, bismuth, tetracycline and metronidazole should be reserved to eradication failures.
authors.affiliation: Universitätsklinikum der Otto-von-Guerike-Universität Magdeburg. gerhard.treiber@medizin.uni-magdeburg.de
authors.forename: G
authors.initials: G
authors.lastname: Treiber
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents